Science
B.C. particle accelerator scores triumph with deal to produce ‘rarest drug on earth’ – q107.com
UBC’s TRIUMF facility is gearing up to produce actinium-225, a rare radioisotope that early research shows could have a powerful effect fighting cancer.
A team at the Canada’s particle accelerator facility at the University of British Columbia is celebrating a major triumph, inking a deal to produce a rare cancer drug that previously relied on nuclear waste.
The TRIUMF project has formed a partnership with Ontario-based Fusion Pharmaceuticals to upgrade its facility to produce actinium-225, nicknamed “the rarest drug on Earth.”
Read more: BWXT Peterborough touts ‘tremendous progress’ in medical isotope production at Darlington nuclear station
That…
-
General12 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News21 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News12 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News19 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime